Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
Cancers|November 13, 2021
Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular CarcinomaMarkus Sebastian Jördens, Lisa Heinrichs, Sven H Loosen, et al.Diagnostics (Basel, Switzerland)|August 14, 2020
Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill PatientsTheresa H Wirtz, Sven H Loosen, Lukas Buendgens, et al.Cells|May 14, 2022
LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular CarcinomaRossella Pellegrino, Mirco Castoldi, Fabio Ticconi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2019
Diagnostic and prognostic biomarkers in cholangiocarcinomaRocio I R Macias, Miroslaw Kornek, Pedro M Rodrigues, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 18, 2021
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysisSven H Loosen, Max Schulze-Hagen, Mihael Vucur, et al.Scientific Reports|October 7, 2025
Circulating extracellular vesicles predict outcome in patient undergoing transjugular intrahepatic portosystemic shunt (TIPS) placementSven H Loosen, Frederik J Hansen, Denis Schatilow, et al.Journal of Clinical Medicine|April 3, 2021
Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor TherapySven H Loosen, Vincent van den Bosch, Joao Gorgulho, et al.Diagnostics (Basel, Switzerland)|November 27, 2021
Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver MetastasesSven H Loosen, Christoph Roderburg, Patrick H Alizai, et al.Journal of Clinical Medicine|September 9, 2020
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors-Results from an Exploratory StudyBurcin Özdirik, Anna K Stueven, Raphael Mohr, et al.International Journal of Molecular Sciences|July 2, 2021
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable CholangiocarcinomaChristoph Roderburg, Sven H Loosen, Jan Bednarsch, et al.Pageof 19